2015-2019 European Infectious Disease Molecular Diagnostics Market: Supplier Shares, Country Forecasts, Innovative Technologies, Competitive Strategies
Complete report $11,800. DataPack (test volumes, sales forecasts, supplier shares) $7,700. The report is available by country, section, market segment, individual test, and can be custom-tailored to your specific information needs and budget.
This new five-country study from VPGMarketResearchcontains 700 pages, 54 tables, and is designed to help current suppliers and potential market entrants identify and evaluate emerging opportunities in the infectious disease molecular diagnosticsmarket during the next five years.
Report Highlights
The infectious disease molecular diagnostics market is one of the most rapidly growing segments of the in vitro diagnostics industry. The next five years will witness significant developments in reagent systems and automation, as well as introduction of a wide range of new products that will require innovative marketing approaches. The rate of market penetration into routine clinical laboratories, however, will depend on the introduction of cost-effective and automated systems with amplification methods.
In order to successfully capitalize on the opportunities presented by the infectious disease molecular diagnostics market, many companies are already exploiting new molecular technologies as corporate strategic assets, managed in support of business and marketing strategies. Integrating new technology planning with business and corporate strategies will be one of the most challenging tasks for diagnostic companies during the next five years.
Geographic Coverage
Extensive strategic assessments of major suppliers and emerging market entrants, including their sales, product portfolios, marketing tactics, collaborative arrangements and new technologies/products in R&D.
Opportunities and Strategic Recommendations
This new five-country study from VPGMarketResearchcontains 700 pages, 54 tables, and is designed to help current suppliers and potential market entrants identify and evaluate emerging opportunities in the infectious disease molecular diagnosticsmarket during the next five years.
Report Highlights
- Business and technological trends in major markets
- Five-year test volume and sales forecasts
- Market shares of leading competitors
- Feature comparison of major analyzers
- Strategic profiles of leading market players and start-up firms developing innovative products
- Specific product and business opportunities for instrument and consumable suppliers.
The infectious disease molecular diagnostics market is one of the most rapidly growing segments of the in vitro diagnostics industry. The next five years will witness significant developments in reagent systems and automation, as well as introduction of a wide range of new products that will require innovative marketing approaches. The rate of market penetration into routine clinical laboratories, however, will depend on the introduction of cost-effective and automated systems with amplification methods.
In order to successfully capitalize on the opportunities presented by the infectious disease molecular diagnostics market, many companies are already exploiting new molecular technologies as corporate strategic assets, managed in support of business and marketing strategies. Integrating new technology planning with business and corporate strategies will be one of the most challenging tasks for diagnostic companies during the next five years.
Geographic Coverage
- France
- Germany
- Italy
- Spain
- UK
- Laboratories performing DNA sequencing and molecular diagnostic testingfor infectious diseases bycountry and market segment.
- Five-year test volume and sales projections by country.
- Sales and market shares of leading suppliers of infectious disease molecular diagnosticreagent kits and components.
- Five-year test volume and sales projections for over 40 infectious disease molecular diagnostic assays.
- A comprehensive analysis of the sequencing market by country and laboratory segment.
- Detailed market segmentation analysis, including review of the market dynamics, trends, structure, size, growth and major suppliers by country.
- Comparison of leading infectious disease molecular diagnosticanalyzers.
- Extensive review of molecular diagnostic technologies, test formats, detection methodologies, trends in testing automation and over target/signal amplification methods.
- Worldwide listings of companies, universities and research centers developing new molecular diagnostictechnologies and products.
Extensive strategic assessments of major suppliers and emerging market entrants, including their sales, product portfolios, marketing tactics, collaborative arrangements and new technologies/products in R&D.
- Abbott
- Affymetrix
- Agilent Technologies
- Applied Gene Technologies
- Arca Biopharma
- Beckman Coulter/Danaher
- Becton Dickinson
- Biokit
- BioMerieux
- Bio-Rad
- Biotest
- Cepheid
- CellMark Forensics Lab/Corp
- Decode Genetics
- Diadexus
- Eiken
- Elitech Group
- Enzo
- Exact Sciences
- Fujirebio
- Grifols
- Hologic/Gen-Probe
- Illumina
- Kreatech/Leica
- Li-Cor Biosciences
- Monogram Biosciences
- Myriad Genetics
- Ortho-Clinical Diagnostics
- Perkin Elmer/Caliper
- Proteome Sciences
- Qiagen
- Roche
- Scienion
- Sequenom
- Shimadzu
- Siemens
- Sierra Molecular
- Takara Bio
- Tecan Group
- Thermo Fisher
Opportunities and Strategic Recommendations
- Specific new product development opportunities with potentially significant market appeal during the next five years.
- Design criteria for new products.
- Alternative market penetration strategies.
- Potential market entry barriers and risks.
- Business planning issues and concerns.
INTRODUCTION
GLOBAL MARKET TRENDS AND EMERGING TECHNOLOGIES
A. DNA Sequencing
B. DNA And RNA Probe Technology
C. Detection Technologies
D. Instrumentation: Review of Automated and Semi-Automated Analyzers
E. Biochips: Genosensors, Microarrays, Labs-on-the-Chip
F. Pharmacogenomics
G. Major Molecular Infectious Diseases Tests
AIDS
Background
Diagnostic Tests
Vaccines and Drugs
Adenovirus/Adeno-Associated Viruses (AAV)
Background
Diagnostic Tests
Vaccines and Drugs
Anthrax/Bacillus Anthracis
Background
Diagnostic Tests
Vaccines and Drugs
Babesiosis
Background
Diagnostic Tests
Vaccines and Drugs
BEA and Other Bartonella Diseases
Background
Diagnostic Tests
Vaccines and Drugs
Chagas Disease
Background
Diagnostic Tests
Vaccines and Drugs
Campylobacter
Background
Diagnostic Tests
Vaccines and Drugs
Chlamydia
Background
Diagnostic Tests
Vaccines and Drugs
Creutzfeldt-Jakob's Disease
Background
Diagnostic Tests
Vaccines and Drugs
Cytomegalovirus
Background
Diagnostic Tests
Vaccines and Drugs
Ebola Virus
Background
Diagnostic Tests
Vaccines and Drugs
Echovirus
Background
Diagnostic Tests
Vaccines and Drugs
Encephalitis
Background
Diagnostic Tests
Vaccines and Drugs
Enteroviruses
Background
Diagnostic Tests
Vaccines and Drugs
Epstein-Barr Virus
Background
Diagnostic Tests
Vaccines and Drugs
Gonorrhea
Background
Diagnostic Tests
Vaccines and Drugs
Hepatitis A, B, C, D, E, G
Background
Diagnostic Tests
Vaccines and Drugs
Herpes Simplex Virus
Background
Diagnostic Tests
Vaccines and Drugs
Legionella
Background
Diagnostic Tests
Vaccines and Drugs
Lyme Disease
Background
Diagnostic Tests
Vaccines and Drugs
Malaria
Background
Diagnostic Tests
Vaccines and Drugs
Mycoplasma
Background
Diagnostic Tests
Vaccines and Drugs
Papillomaviruses/HPV
Background
Diagnostic Tests
Vaccines and Drugs
Parvovirus B19
Background
Diagnostic Tests
Vaccines and Drugs
Pneumonia
Background
Diagnostic Tests
Vaccines and Drugs
Polyomaviruses
Background
Diagnostic Tests
Vaccines and Drugs
Salmonellosis
Background
Diagnostic Tests
Vaccines and Drugs
Shigellosis
Background
Diagnostic Tests
Vaccines and Drugs
Streptococci A, B
Background
Diagnostic Tests
Vaccines and Drugs
Toxoplasmosis
Background
Diagnostic Tests
Vaccines and Drugs
Tuberculosis
Background
Diagnostic Tests
Vaccines and Drugs
West Nile Virus
Background
Diagnostic Tests
Vaccines and Drugs
Yersinia
Background
Diagnostic Tests
Vaccines and Drugs
H. Competing/Complementing Technologies
France
A. Executive Summary
B. Business Environment
C. Market Structure
D. Market Dynamics, Trends, Size and Growth
Volume Forecasts by Test and Market Segment
Sales Forecasts by Test and Market Segment
Major Supplier Sales and Market Shares
Germany
A. Executive Summary
B. Business Environment
C. Market Structure
D. Market Dynamics, Trends, Size and Growth
Volume Forecasts by Test and Market Segment
Sales Forecasts by Test and Market Segment
Major Supplier Sales and Market Shares
Italy
A. Executive Summary
B. Business Environment
C. Market Structure
D. Market Dynamics, Trends, Size and Growth
Volume Forecasts by Test and Market Segment
Sales Forecasts by Test and Market Segment
Major Supplier Sales and Market Shares
Spain
A. Executive Summary
B. Business Environment
C. Market Structure
D. Market Dynamics, Trends, Size and Growth
Volume Forecasts by Test and Market Segment
Sales Forecasts by Test and Market Segment
Major Supplier Sales and Market Shares
U.K.
A. Executive Summary
B. Business Environment
C. Market Structure
D. Market Dynamics, Trends, Size and Growth
Volume Forecasts by Test and Market Segment
Sales Forecasts by Test and Market Segment
Major Supplier Sales and Market Shares
MAJOR PRODUCT DEVELOPMENT OPPORTUNITIES
A. Opportunities for New Instrumentation
B. Opportunities for New Reagent Kits and Test Systems/Panels
C. Opportunities for New IT, Computers, Software and Automation
D. Opportunities for New Auxiliary Products
DESIGN CRITERIA FOR DECENTRALIZED TESTING PRODUCTS
ALTERNATIVE MARKET PENETRATION STRATEGIES
POTENTIAL MARKET ENTRY BARRIERS AND RISKS
COMPETITIVE PROFILES
Abbott
Affymetrix
Agilent Technologies
Applied Gene Technologies
Arca/Nuvelo
Beckman Coulter/Danaher
Becton Dickinson
Biokit
BioMerieux
Bio-Rad
Biotest
Caliper
Cepheid
Decode
Diadexus
Eiken
Enzo
Exact Sciences
Fujirebio/Innogenetics
Grifols
Hologic/Gen-Probe
Illumina
Kreatech
Li-Cor Biosciences
Life Technologies/Thermo Fisher
Monogram Biosciences
Myriad Genetics
Nanogen/Elitech
Orchid CellMark
Ortho-Clinical Diagnostics
Proteome Sciences
Qiagen
Roche
Scienion
Sequenom
Shimadzu
Siemens
Sierra Molecular Takara Bio
Tecan Group
APPENDIXES
GLOBAL MARKET TRENDS AND EMERGING TECHNOLOGIES
A. DNA Sequencing
B. DNA And RNA Probe Technology
C. Detection Technologies
D. Instrumentation: Review of Automated and Semi-Automated Analyzers
E. Biochips: Genosensors, Microarrays, Labs-on-the-Chip
F. Pharmacogenomics
G. Major Molecular Infectious Diseases Tests
AIDS
Background
Diagnostic Tests
Vaccines and Drugs
Adenovirus/Adeno-Associated Viruses (AAV)
Background
Diagnostic Tests
Vaccines and Drugs
Anthrax/Bacillus Anthracis
Background
Diagnostic Tests
Vaccines and Drugs
Babesiosis
Background
Diagnostic Tests
Vaccines and Drugs
BEA and Other Bartonella Diseases
Background
Diagnostic Tests
Vaccines and Drugs
Chagas Disease
Background
Diagnostic Tests
Vaccines and Drugs
Campylobacter
Background
Diagnostic Tests
Vaccines and Drugs
Chlamydia
Background
Diagnostic Tests
Vaccines and Drugs
Creutzfeldt-Jakob's Disease
Background
Diagnostic Tests
Vaccines and Drugs
Cytomegalovirus
Background
Diagnostic Tests
Vaccines and Drugs
Ebola Virus
Background
Diagnostic Tests
Vaccines and Drugs
Echovirus
Background
Diagnostic Tests
Vaccines and Drugs
Encephalitis
Background
Diagnostic Tests
Vaccines and Drugs
Enteroviruses
Background
Diagnostic Tests
Vaccines and Drugs
Epstein-Barr Virus
Background
Diagnostic Tests
Vaccines and Drugs
Gonorrhea
Background
Diagnostic Tests
Vaccines and Drugs
Hepatitis A, B, C, D, E, G
Background
Diagnostic Tests
Vaccines and Drugs
Herpes Simplex Virus
Background
Diagnostic Tests
Vaccines and Drugs
Legionella
Background
Diagnostic Tests
Vaccines and Drugs
Lyme Disease
Background
Diagnostic Tests
Vaccines and Drugs
Malaria
Background
Diagnostic Tests
Vaccines and Drugs
Mycoplasma
Background
Diagnostic Tests
Vaccines and Drugs
Papillomaviruses/HPV
Background
Diagnostic Tests
Vaccines and Drugs
Parvovirus B19
Background
Diagnostic Tests
Vaccines and Drugs
Pneumonia
Background
Diagnostic Tests
Vaccines and Drugs
Polyomaviruses
Background
Diagnostic Tests
Vaccines and Drugs
Salmonellosis
Background
Diagnostic Tests
Vaccines and Drugs
Shigellosis
Background
Diagnostic Tests
Vaccines and Drugs
Streptococci A, B
Background
Diagnostic Tests
Vaccines and Drugs
Toxoplasmosis
Background
Diagnostic Tests
Vaccines and Drugs
Tuberculosis
Background
Diagnostic Tests
Vaccines and Drugs
West Nile Virus
Background
Diagnostic Tests
Vaccines and Drugs
Yersinia
Background
Diagnostic Tests
Vaccines and Drugs
H. Competing/Complementing Technologies
France
A. Executive Summary
B. Business Environment
C. Market Structure
D. Market Dynamics, Trends, Size and Growth
Volume Forecasts by Test and Market Segment
Sales Forecasts by Test and Market Segment
Major Supplier Sales and Market Shares
Germany
A. Executive Summary
B. Business Environment
C. Market Structure
D. Market Dynamics, Trends, Size and Growth
Volume Forecasts by Test and Market Segment
Sales Forecasts by Test and Market Segment
Major Supplier Sales and Market Shares
Italy
A. Executive Summary
B. Business Environment
C. Market Structure
D. Market Dynamics, Trends, Size and Growth
Volume Forecasts by Test and Market Segment
Sales Forecasts by Test and Market Segment
Major Supplier Sales and Market Shares
Spain
A. Executive Summary
B. Business Environment
C. Market Structure
D. Market Dynamics, Trends, Size and Growth
Volume Forecasts by Test and Market Segment
Sales Forecasts by Test and Market Segment
Major Supplier Sales and Market Shares
U.K.
A. Executive Summary
B. Business Environment
C. Market Structure
D. Market Dynamics, Trends, Size and Growth
Volume Forecasts by Test and Market Segment
Sales Forecasts by Test and Market Segment
Major Supplier Sales and Market Shares
MAJOR PRODUCT DEVELOPMENT OPPORTUNITIES
A. Opportunities for New Instrumentation
B. Opportunities for New Reagent Kits and Test Systems/Panels
C. Opportunities for New IT, Computers, Software and Automation
D. Opportunities for New Auxiliary Products
DESIGN CRITERIA FOR DECENTRALIZED TESTING PRODUCTS
ALTERNATIVE MARKET PENETRATION STRATEGIES
POTENTIAL MARKET ENTRY BARRIERS AND RISKS
COMPETITIVE PROFILES
Abbott
Affymetrix
Agilent Technologies
Applied Gene Technologies
Arca/Nuvelo
Beckman Coulter/Danaher
Becton Dickinson
Biokit
BioMerieux
Bio-Rad
Biotest
Caliper
Cepheid
Decode
Diadexus
Eiken
Enzo
Exact Sciences
Fujirebio/Innogenetics
Grifols
Hologic/Gen-Probe
Illumina
Kreatech
Li-Cor Biosciences
Life Technologies/Thermo Fisher
Monogram Biosciences
Myriad Genetics
Nanogen/Elitech
Orchid CellMark
Ortho-Clinical Diagnostics
Proteome Sciences
Qiagen
Roche
Scienion
Sequenom
Shimadzu
Siemens
Sierra Molecular Takara Bio
Tecan Group
APPENDIXES
LIST OF TABLES
Major Companies Developing or Marketing AIDS Molecular Diagnostic And Other Direct Identification Tests
Major Companies Developing or Marketing Adenovirus Molecular Diagnostic And Other Direct Identification Tests
Major Companies Developing or Marketing Campylobacter Molecular Diagnostic And Other Direct Identification Tests
Major Companies Developing or Marketing Chlamydia Molecular Diagnostic And Other Direct Identification Tests
Major Companies Developing or Marketing CMV Molecular Diagnostic And Other Direct Identification Tests
Major Companies Developing or Marketing EBV Molecular Diagnostic And Other Direct Identification Tests
Major Companies Developing or Marketing Gonorrhea Molecular Diagnostic And Other Direct Identification Tests
Major Companies Developing or Marketing Hepatitis Molecular Diagnostic And Other Direct Identification Tests
Major Companies Developing or Marketing Herpes Molecular Diagnostic And Other Direct Identification Tests
Major Companies Developing or Marketing Legionella Molecular Diagnostic And Other Direct Identification Tests
Major Companies Developing or Marketing Lyme Disease Molecular Diagnostic And Other Direct Identification Tests
Major Companies Developing or Marketing Mycoplasma Molecular Diagnostic And Other Direct Identification Tests
Major Companies Developing or Marketing Papilloma Virus Molecular Diagnostic And Other Direct Identification Tests
Major Companies Developing or Marketing Pneumonia Molecular Diagnostic And Other Direct Identification Tests
Major Companies Developing or Marketing Salmonella Molecular Diagnostic And Other Direct Identification Tests
Major Companies Developing or Marketing Shigella Molecular Diagnostic And Other Direct Identification Tests
Major Companies Developing or Marketing Streptococci Molecular Diagnostic And Other Direct Identification Tests
Major Companies Developing or Marketing Toxoplasmosis Molecular Diagnostic And Other Direct Identification Tests
Major Companies Developing or Marketing Tuberculosis Molecular Diagnostic And Other Direct Identification Tests
France, Laboratories Performing DNA Sequencing By Market Segment
France, Molecular Diagnostics Market Potential Laboratory Universe by Market Segment
France, Major Infectious Disease Molecular Diagnostics Test Volume Forecast
France, Infectious Disease Screening NAT Volume Forecast
France, Infectious Disease Screening NAT Reagent Market Forecast by Test
France, Molecular Diagnostics Market By Major Supplier
France, HIV/Hepatitis NAT Market Reagent Sales By Major Supplier
Germany, Laboratories Performing DNA Sequencing by Market Segment
Germany, Molecular Diagnostics Market Potential Laboratory Universe by Market Segment
Germany, Major Infectious Disease Molecular Diagnostics Test Volume Forecast
Germany, Infectious Disease Screening NAT Volume Forecast
Germany, Infectious Disease Screening NAT Reagent Market Forecast by Test
Germany, Molecular Diagnostics Market by Major Supplier
Germany, HIV/Hepatitis NAT Market Reagent Sales by Major Supplier
Italy, Laboratories Performing DNA Sequencing by Market Segment
Italy, Molecular Diagnostics Market Potential Laboratory Universe by Market Segment
Italy, Major Infectious Disease Molecular Diagnostics Test Volume Forecast
Italy, Infectious Disease Screening NAT Volume Forecast
Italy, Infectious Disease Screening NAT Reagent Market Forecast by Test
Italy, Molecular Diagnostics Market By Major Supplier
Italy, HIV/Hepatitis NAT Market By Major Supplier
Spain, Laboratories Performing DNA Sequencing by Market Segment
Spain, Molecular Diagnostics Market, Potential Laboratory Universe by Market Segment
Spain, Major Infectious Disease Molecular Diagnostics Test Volume Forecast
Spain, Infectious Disease Screening NAT Volume Forecast
Spain, Infectious Disease Screening Nat Reagent Market Forecast by Test
Spain, Molecular Diagnostics Market By Major Supplier
Spain, HIV/Hepatitis NAT Market Reagent Sales by Major Supplier
U.K., Laboratories Performing Dna Sequencing by Market Segment
U.K., Molecular Diagnostics Market Potential Laboratory Universe by Market Segment
U.K., Major Infectious Disease Molecular Diagnostics Test Volume Forecast
U.K., Infectious Disease Screening NAT Volume Forecast
U.K., Infectious Disease Screening NAT Reagent Market Forecast by Test
U.K., Molecular Diagnostics Market by Major Supplier
U.K., HIV/Hepatitis NAT Market Reagent Sales by Major Supplier
Major Companies Developing or Marketing AIDS Molecular Diagnostic And Other Direct Identification Tests
Major Companies Developing or Marketing Adenovirus Molecular Diagnostic And Other Direct Identification Tests
Major Companies Developing or Marketing Campylobacter Molecular Diagnostic And Other Direct Identification Tests
Major Companies Developing or Marketing Chlamydia Molecular Diagnostic And Other Direct Identification Tests
Major Companies Developing or Marketing CMV Molecular Diagnostic And Other Direct Identification Tests
Major Companies Developing or Marketing EBV Molecular Diagnostic And Other Direct Identification Tests
Major Companies Developing or Marketing Gonorrhea Molecular Diagnostic And Other Direct Identification Tests
Major Companies Developing or Marketing Hepatitis Molecular Diagnostic And Other Direct Identification Tests
Major Companies Developing or Marketing Herpes Molecular Diagnostic And Other Direct Identification Tests
Major Companies Developing or Marketing Legionella Molecular Diagnostic And Other Direct Identification Tests
Major Companies Developing or Marketing Lyme Disease Molecular Diagnostic And Other Direct Identification Tests
Major Companies Developing or Marketing Mycoplasma Molecular Diagnostic And Other Direct Identification Tests
Major Companies Developing or Marketing Papilloma Virus Molecular Diagnostic And Other Direct Identification Tests
Major Companies Developing or Marketing Pneumonia Molecular Diagnostic And Other Direct Identification Tests
Major Companies Developing or Marketing Salmonella Molecular Diagnostic And Other Direct Identification Tests
Major Companies Developing or Marketing Shigella Molecular Diagnostic And Other Direct Identification Tests
Major Companies Developing or Marketing Streptococci Molecular Diagnostic And Other Direct Identification Tests
Major Companies Developing or Marketing Toxoplasmosis Molecular Diagnostic And Other Direct Identification Tests
Major Companies Developing or Marketing Tuberculosis Molecular Diagnostic And Other Direct Identification Tests
France, Laboratories Performing DNA Sequencing By Market Segment
France, Molecular Diagnostics Market Potential Laboratory Universe by Market Segment
France, Major Infectious Disease Molecular Diagnostics Test Volume Forecast
France, Infectious Disease Screening NAT Volume Forecast
France, Infectious Disease Screening NAT Reagent Market Forecast by Test
France, Molecular Diagnostics Market By Major Supplier
France, HIV/Hepatitis NAT Market Reagent Sales By Major Supplier
Germany, Laboratories Performing DNA Sequencing by Market Segment
Germany, Molecular Diagnostics Market Potential Laboratory Universe by Market Segment
Germany, Major Infectious Disease Molecular Diagnostics Test Volume Forecast
Germany, Infectious Disease Screening NAT Volume Forecast
Germany, Infectious Disease Screening NAT Reagent Market Forecast by Test
Germany, Molecular Diagnostics Market by Major Supplier
Germany, HIV/Hepatitis NAT Market Reagent Sales by Major Supplier
Italy, Laboratories Performing DNA Sequencing by Market Segment
Italy, Molecular Diagnostics Market Potential Laboratory Universe by Market Segment
Italy, Major Infectious Disease Molecular Diagnostics Test Volume Forecast
Italy, Infectious Disease Screening NAT Volume Forecast
Italy, Infectious Disease Screening NAT Reagent Market Forecast by Test
Italy, Molecular Diagnostics Market By Major Supplier
Italy, HIV/Hepatitis NAT Market By Major Supplier
Spain, Laboratories Performing DNA Sequencing by Market Segment
Spain, Molecular Diagnostics Market, Potential Laboratory Universe by Market Segment
Spain, Major Infectious Disease Molecular Diagnostics Test Volume Forecast
Spain, Infectious Disease Screening NAT Volume Forecast
Spain, Infectious Disease Screening Nat Reagent Market Forecast by Test
Spain, Molecular Diagnostics Market By Major Supplier
Spain, HIV/Hepatitis NAT Market Reagent Sales by Major Supplier
U.K., Laboratories Performing Dna Sequencing by Market Segment
U.K., Molecular Diagnostics Market Potential Laboratory Universe by Market Segment
U.K., Major Infectious Disease Molecular Diagnostics Test Volume Forecast
U.K., Infectious Disease Screening NAT Volume Forecast
U.K., Infectious Disease Screening NAT Reagent Market Forecast by Test
U.K., Molecular Diagnostics Market by Major Supplier
U.K., HIV/Hepatitis NAT Market Reagent Sales by Major Supplier